Efficacy and Safety of Suvorexant (MK-4305) for Reducing Incidence of Delirium in Japanese Participants at High Risk of Delirium (MK-4305-085)
Clinical trial NCT04571944 · COMPLETED
Trial details
- NCT number
- NCT04571944
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-10-22
- Primary completion
- 2022-12-23
- Enrollment
- 207
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.